ArticleAmerican journal of preventive cardiology2026
Clinical and demographic profiles of people not meeting LDL-C goals after treatment with a proprotein convertase subtilisin/kexin type 9 inhibitor.
Li Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.